anonymous
Guest
anonymous
Guest
I know so many are super excited about the new MS drug. That being said, the drug won't be easy to sell. It's a super tough market, many neurologists are very tough to see, the training will be terrible, and the disease state is difficult to learn. There is also a lot of competition for the few scripts that are out there. I'd say "buyer beware". If you have a job, think about it before you leave. If you don't, then jump at the chance if you are able to be part of their "club". The arrogance of Genentech reps on this board makes me not want to work here. I've never seen anything like it.
Good luck.
Good luck.